Fundamental Analysis · Last Quarter

FA

A dedicated fundamental analysis might help you to get a quick overview of the financial stability. However it is important to understand the FA Algorithm and the criterias before valuing it as a solution.

See FA Rationale
Framework:
Valuation Somewhat Positive
56%
Profitability n.A.
Fin. Growth Weak
33%
Leverage & Liquidity Balanced
50%
Per Share Metrics Positive
67%
Fin. Health n.A.
Fundamentals

Valuation

Metric Q1 Q2 Δ in %
EV/EBITDA -3081.15 -1121.83 -35.26
Graham Fair Price -31.17 5.37 7.80
PEG 556.93 0.14 0.02
Price/Book -19.47 0.50 0.62
Price/Cash Flow 224.76 6.68 -2.06
Prices/Earnings -63.88 -7.00 -4.27
Price/Sales -42.01 0.58 1.00
Price/FCF 224.76 6.68 -2.06
Naive Interpretation member
01 - Valuation · Somewhat Positive
Fundamentals

Profitability

Metric Q1 Q2 Δ in %
Gross Profit Margin 1760.89 0.12 < 0.005
Operating Margin 67.05 -0.02 -0.05
ROA 52.17 < 0.005 -0.02
ROE -0.04 -0.02 50.86
ROIC -0.02 -0.01 46.46
Naive Interpretation member
02 - Profitability · Not Interpreted
Fundamentals

Financial Growth

Metric Q1 Q2 Δ in %
Debt QOQ -0.02 -0.13 82.74
Dividends QOQ -0.25 0.58 127.81
EBIT QOQ -2.06 0.55 -73.28
EPS QOQ -2.07 0.52 -75.05
FCF QOQ -2.19 1.24 -43.10
Revenue QOQ -0.28 0.36 28.82
Naive Interpretation member
03 - Financial Growth · Weak
Fundamentals

Leverage & Liquidity

Metric Q1 Q2 Δ in %
Assets Turnover n.A. n.A. n.A.
Days Inventory Outstanding (DIO) 76.38 64.52 -15.52
Days Sales Outstanding (DSO) 9.59 20.05 109.00
Inventory Turnover 1.18 1.39 18.38
Debt/Capitalization 0.45 0.45 0.09
Quick Ratio 1.96 2.06 5.14
Naive Interpretation member
04 - Leverage & Liquidity · Balanced
Fundamentals

Per Share Metrics

Metric Q1 Q2 Δ in %
Book Value 8.63 8.90 3.13
Cash 3.21 3.44 6.98
Capex -0.03 0.03 14.34
Free Cash Flow -2.60 0.63 -75.65
Revenue 5.37 7.32 36.35
Naive Interpretation member
05 - Per Share Metrics · Positive
Fundamentals

Financial Health

Metric Q1 Q2 Δ in %
Current Ratio 5.04 3.83 -24.08
Debt/Assets n.A. n.A. n.A.
Debt/Equity n.A. n.A. n.A.
Net Debt/EBITDA -14.75 -486.85 -3201.38
Naive Interpretation Member
06 - Financial Health · Bad
Rating